Taiwan FDA registration cd43a0d0847b3735959954b0af81b49f

Beckman Coulter Coulin Negative Urine Correction Solution for Drug Abuse

TW: 貝克曼庫爾特協康藥物濫用陰性尿液校正液

Taiwan·Risk Class 2·BECKMAN COULTER INC.·Registered Apr 06, 2017 – Apr 06, 2027Active

Registration details

Analysis ID: cd43a0d0847b3735959954b0af81b49f
Customs Code: DHA05602953102

Company information

Manufacturer: BECKMAN COULTER INC.
Manufacturer Country: United States
Authorized Representative: BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.)

Product details

Intended Use: This product is used in conjunction with SYNCHRON reagent for correction during enzyme immunoassay of amphetamines, barbiturates, benzodiazepine, cannabis (20ng, 50ng, 100ng), cocaine, methadone, whiteboard, opium, angel dust, and pramixifen on the SYNCHRON system.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.3200 Clinical Toxicology Corrector
Import Information: import

Dates and status

Registration Date: Apr 06, 2017
Expiry Date: Apr 06, 2027

About this record

Access comprehensive regulatory information for Beckman Coulter Coulin Negative Urine Correction Solution for Drug Abuse in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number cd43a0d0847b3735959954b0af81b49f and manufactured by BECKMAN COULTER INC.. The authorized representative in Taiwan is BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.